BiotechTube
CORONIS

CORONIS

Athens, Europe - Other· Est.
coronis.gr
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CORONIS is a privately-held, full-service Contract Research Organization (CRO) operating across Europe, with over two decades of experience in clinical trial management and pharmaceutical consulting. The company offers a comprehensive suite of services spanning clinical development (Phase I-IV), real-world data studies, regulatory affairs, pharmacovigilance, and post-market commercialization support. As a service provider, its business model is fee-for-service, generating revenue by supporting client projects rather than developing its own therapeutic assets. CORONIS positions itself as a strategic partner for navigating the complex European regulatory landscape and accelerating product development.

DiagnosticsDigital Health

Technology Platform

Integrated CRO service platform including clinical trial management systems, proprietary iCOS real-world data (RWD) platform for registries and observational studies, and standardized methodologies for regulatory affairs and pharmacovigilance.

Opportunities

Growing demand for Real-World Evidence (RWE) and post-authorization studies presents a key opportunity for its iCOS platform services.
As a EU-based CRO, it is strategically positioned to help global sponsors navigate complex and evolving European regulations (EMA, MDR, IVDR).
The industry trend towards functional outsourcing (FSP) and specialized service providers allows a mid-sized CRO like CORONIS to offer flexible, high-touch support.

Risk Factors

Faces intense competition from large, global CROs with greater resources.
Revenue is dependent on the cyclical R&D spending of pharmaceutical and biotech clients, creating potential volatility.
Operational risks include failure to execute clinical trials effectively, maintain regulatory compliance, or ensure data integrity, which could damage reputation.

Competitive Landscape

Operates in the highly fragmented and competitive global CRO market. Competes with large multinational CROs (e.g., IQVIA, ICON, Parexel, PPD) and numerous small-to-mid-sized regional and niche CROs across Europe. Differentiation is based on regional expertise, service quality, therapeutic specialization, and cost.

More companies in Europe - Other →